Literature DB >> 8722381

Helicobacter pylori infection and dyspepsia.

D Armstrong1.   

Abstract

It has proved remarkably difficult to confirm or refute an association between Helicobacter pylori-induced gastritis and non-ulcer dyspepsia for several reasons. Dyspepsia has not been defined adequately and current definitions include a variety of symptoms that probably reflect a number of underlying pathophysiological processes. Dyspepsia is a symptom complex, rather than a specific disease entity, and cannot be easily identified. There are probably many causes of dyspepsia, and if H. pylori does cause symptoms, it may produce different symptoms in different people. However, little is known about variations in host susceptibility and H. pylori virulence, or their potential effect on symptomatology. In addition, the mechanisms responsible for dyspeptic symptoms are unknown, regardless of whether or not there is concomitant H. pylori-induced inflammation. A possible aetiological role for H. pylori in dyspepsia has been sought in three major types of study. Epidemiology studies have suggested that H. pylori is not a major cause of non-ulcer dyspepsia. However, both dyspepsia and H. pylori are common, and the studies cannot account for many of the variables detailed above. Pathophysiological studies have commonly reported a variety of motor and sensory 'abnormalities' in association with H. pylori, but none has been confirmed or reproduced. In eradication studies, there is continuing debate as to whether dyspeptic symptoms diminish with treatment. This is partly because of the high placebo-response rate and partly because many treatment regimens have not cured the infection. Suppression of bacterial growth may not affect symptoms significantly, if they are due to mucosal inflammation, and symptom resolution may take many weeks or months following cure of H. pylori and the associated gastritis. Recent findings have shown that symptom reduction is more evident 1 year after eradication of H. pylori than after 4 weeks. There is a continuing and urgent need for well-designed studies to assess the long-term effect of H. pylori and its cure on both gastrointestinal function and dyspeptic symptoms.

Entities:  

Mesh:

Year:  1996        PMID: 8722381

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  36 in total

1.  The Association of Helicobacter pylori Infection With Nonulcer Dyspepsia.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-02       Impact factor: 3.725

2.  Helicobacter pylori infection.

Authors:  Yvan Vandenplas
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

3.  Treating non-ulcer dyspepsia and H pylori.

Authors:  S J van Zanten
Journal:  BMJ       Date:  2000-09-16

Review 4.  Helicobacter pylori eradication in patients with non-ulcer dyspepsia.

Authors:  H H Xia; N J Talley
Journal:  Drugs       Date:  1999-11       Impact factor: 9.546

5.  Symptom improvement after helicobacter pylori eradication in patients with functional dyspepsia-A multicenter, randomized, prospective cohort study.

Authors:  Sanping Xu; Xueming Wan; Xiaolan Zheng; Yali Zhou; Zhiqiang Song; Minghu Cheng; Yiqi Du; Xiaohua Hou
Journal:  Int J Clin Exp Med       Date:  2013-09-25

6.  Evaluation of Helicobacter pylori status and endoscopic findings among new outpatients with dyspepsia in Japan.

Authors:  Seiji Shiota; Kazunari Murakami; Akiko Takayama; Shigeaki Yasaka; Tadayoshi Okimoto; Aoi Yoshiiwa; Masaaki Kodama; Toshio Fujioka
Journal:  J Gastroenterol       Date:  2009-07-01       Impact factor: 7.527

7.  An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group.

Authors:  S J Veldhuyzen van Zanten; N Flook; N Chiba; D Armstrong; A Barkun; M Bradette; A Thomson; F Bursey; P Blackshaw; D Frail; P Sinclair
Journal:  CMAJ       Date:  2000-06-13       Impact factor: 8.262

8.  Helicobacter pylori eradication versus prokinetics in the treatment of functional dyspepsia: a randomized, double-blind study.

Authors:  Tiing Leong Ang; Kwong Ming Fock; Eng Kiong Teo; Yiong Huak Chan; Tay Meng Ng; Tju Siang Chua; Jessica Yi-Lyn Tan
Journal:  J Gastroenterol       Date:  2006-07       Impact factor: 7.527

9.  [Helicobacter eradication: an expensive Sisyphus task].

Authors:  H J Wildgrube
Journal:  Med Klin (Munich)       Date:  1998-07-15

10.  The Role of RANTES Promoter Polymorphism in Functional Dyspepsia.

Authors:  Tomomitsu Tahara; Tomoyuki Shibata; Hiromi Yamashita; Ichiro Hirata; Tomiyasu Arisawa
Journal:  J Clin Biochem Nutr       Date:  2009-08-28       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.